{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:13:53Z","timestamp":1771852433074,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["848018102"],"award-info":[{"award-number":["848018102"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The OMED2 (\n                      <jats:italic>Optimization of Medication in Elderly with Diabetes<\/jats:italic>\n                      ) study addresses the effect and implementation of integrating a deprescribing programme (DPP) in general practice. The aim of the DPP is to reduce glucose-lowering medication (SU\/insulin) in overtreated older patients. The protocol for this study has been published previously. This statistical analysis plan (SAP) contains a more elaborate outline of the (statistical) methods we plan to use for data analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The OMED2 study is a randomized mixed-methods study with a 2-year follow-up period that compares the effect of the implementation of a DPP in general practice to regular care (control). In this SAP, we report on the (statistical) approaches that we plan to use to address the study objectives. The main objective of the OMED2 study is to examine the effect of the implementation of the DPP on diabetes complications, whereby the total number of diabetes complications related to undertreatment and overtreatment will be summed. Generalized linear mixed models with a Poisson distribution and the DPP as the main determinant will be used to test whether the total number of diabetes complications occurring from the start of the 2-year follow-up until the end of follow-up differs between intervention and control. The incident rate of the number of diabetes complications will be calculated to correct for possible differences in follow-up duration. The model will also include a random effect variable to allow for possible clustering effects by general practice. We will perform intention-to-treat analyses, which include all patients eligible for deprescribing, as well as per protocol analyses, which omit patients who were not deprescribed in the intervention arm. Additionally, approaches to study the implementation of the DPP and the cost-effectiveness of the implementation are outlined in the SAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ISRCTN Registry ISRCTN50008265. Registered on 1 November 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09442-8","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:46:39Z","timestamp":1769741199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Statistical analysis plan of the study titled \u201cA deprescribing programme aimed to optimize blood glucose-lowering medication in older people with type 2 diabetes mellitus \u2014 the OMED2 study: a randomized controlled trial\u201d"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-1979","authenticated-orcid":false,"given":"Charlotte","family":"Andriessen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke T.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna W.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Ardine","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Herings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J.","family":"van Marum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline G.","family":"Hugtenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liselotte","family":"van Bloemendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giel","family":"Nijpels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimke C.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Denig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra J. M.","family":"Elders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"9442_CR1","doi-asserted-by":"crossref","unstructured":"Andriessen C, Blom MT, van Hoek BA, de Boer AW, Denig P, de Wit GA. A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial. Trials. 2024:25(1);505.","DOI":"10.1186\/s13063-024-08249-9"},{"key":"9442_CR2","doi-asserted-by":"crossref","unstructured":"Andriessen C, Blom MT, van Hoek BA, de Boer AW, Denig P, Herings R, et al. Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderly. Family Practice. 2025:42(5);cmaf064.","DOI":"10.1093\/fampra\/cmaf064"},{"key":"9442_CR3","first-page":"3","volume":"5","author":"E Barents","year":"2018","unstructured":"Barents E, Bilo H, Bouma M, Van den Brink-Muinen A, Dankers M, Van den Donk M. NHG-Standaard Diabetes mellitus type 2 (M01). Versie. 2018;5:3.","journal-title":"Versie"},{"issue":"11","key":"9442_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6","volume":"15","author":"S Borson","year":"2000","unstructured":"Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive \u2018vital signs\u2019 measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15(11):1021\u20137.","journal-title":"Int J Geriatr Psychiatry"},{"key":"9442_CR5","unstructured":"Dutch National Healthcare Institute. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg (versie 2024) [Guidelines for health economic evaluations. Version 2024].\u00a02024."},{"issue":"23","key":"9442_CR6","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","volume":"318","author":"C Gamble","year":"2017","unstructured":"Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dor\u00e9 C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318(23):2337\u201343.","journal-title":"JAMA"},{"issue":"9","key":"9442_CR7","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322\u20137.","journal-title":"Am J Public Health"},{"key":"9442_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/kisup.2012.77","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous R, Coresh J, De Francisco A, De Jong P. Summary of recommendation statements. Kidney Int Suppl. 2013;3:5\u201314.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"9442_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.","journal-title":"BMC Geriatr"},{"key":"9442_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-8-18","volume":"8","author":"C May","year":"2013","unstructured":"May C. Towards a general theory of implementation. Implement Sci. 2013;8:1\u201314.","journal-title":"Implement Sci"},{"key":"9442_CR11","unstructured":"Nederlands Zorginstituut. Kostenhandleiding. Verdiepingsmodule bij de richtlijnen voor economische evaluatie in de zorg.\u00a02024."},{"key":"9442_CR12","unstructured":"Nielen M, Davids R, Gommer M, Poos R, Verheij R. Berekening morbiditeitscijfers op basis van NIVEL Zorgregistraties eerste lijn. Nivel; 2016. Cited 2017 3\u20135\u201317. In."},{"issue":"19","key":"9442_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"R P\u00e1lsson","year":"2021","unstructured":"P\u00e1lsson R, Collaboration, C. K. D. E. New creatinine-and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"6","key":"9442_CR14","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1080\/03610918.2017.1323223","volume":"47","author":"EH Payne","year":"2018","unstructured":"Payne EH, Gebregziabher M, Hardin JW, Ramakrishnan V, Egede LE. An empirical approach to determine a threshold for assessing overdispersion in Poisson and negative binomial models for count data. Communications in Statistics-Simulation and Computation. 2018;47(6):1722\u201338.","journal-title":"Communications in Statistics-Simulation and Computation"},{"key":"9442_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","volume":"30","author":"E Reeve","year":"2013","unstructured":"Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30:793\u2013807.","journal-title":"Drugs Aging"},{"key":"9442_CR16","doi-asserted-by":"crossref","unstructured":"Schielzeth H, Dingemanse NJ, Nakagawa S, Westneat DF, Allegue H, Teplitsky C et al. Robustness of linear mixed\u2010effects models to violations of distributional assumptions. Methods Ecol Evo. 2020:11(9):1141\u20131152.","DOI":"10.1111\/2041-210X.13434"},{"key":"9442_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2023.101100","volume":"34","author":"G Stevens","year":"2023","unstructured":"Stevens G, Dolley S, Mogg R, Connor JT. A template for the authoring of statistical analysis plans. Contemp Clin Trials Commun. 2023;34:101100.","journal-title":"Contemp Clin Trials Commun"},{"key":"9442_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.conctc.2018.03.008","volume":"10","author":"J Twisk","year":"2018","unstructured":"Twisk J, Bosman L, Hoekstra T, Rijnhart J, Welten M, Heymans M. Different ways to estimate treatment effects in randomised controlled trials. Contemp Clin Trials Commun. 2018;10:80\u20135.","journal-title":"Contemp Clin Trials Commun"},{"issue":"4","key":"9442_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"MM Versteegh","year":"2016","unstructured":"Versteegh MM, Vermeulen KM, Evers SM, De Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343\u201352.","journal-title":"Value Health"},{"issue":"2","key":"9442_CR20","doi-asserted-by":"publisher","DOI":"10.2196\/12376","volume":"21","author":"C Vis","year":"2019","unstructured":"Vis C, Ruwaard J, Finch T, Rapley T, de Beurs D, van Stel H, et al. Toward an objective assessment of implementation processes for innovations in health care: psychometric evaluation of the Normalization MeAsure Development (NoMAD) questionnaire among mental health care professionals. J Med Internet Res. 2019;21(2):e12376.","journal-title":"J Med Internet Res"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09442-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:23:40Z","timestamp":1771849420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09442-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9442"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09442-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final version of the statistical analysis plan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}